Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |